Ovestin Ovula, Vaginalovula

7680471830141 CH-47183 Vaginalovula

Associated product:

OVESTIN ovule 0.5 mg 15 pce
Ovestin Ovula, Vaginalovula
Ovestin Ovula, Vaginalovula
Ovestin Ovula, Vaginalovula
1 / 3
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
15
Selling units
15
Measure
Suppositorien
Galenic form
Vaginalovula
Galenic group
Vaginal-Produkte

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/05/2026
Summary of Product Characteristics
Français
13/05/2026
Summary of Product Characteristics
Italien
13/05/2026
Patient information leaflet
Allemand
17/02/2026
Patient information leaflet
Français
17/02/2026
Patient information leaflet
Italien
17/02/2026

Detailed composition

Substance Quantity Type Category
estriolum
0.5 MG Substance Wirkstoff (Principe actif)
adeps solidus
- Substance HNIDK
glyceroli monoricinoleas
- Substance HNIDK
macrogoli aether cetostearylicus
- Substance HNIDK
E 321
0.03 MG Substance HBESI
E 304
- Substance ANTON
acidum citricum
- Substance HNIDK
propylenglycolum
- Substance HBESI

Reimbursement information

Public price
CHF 14.45
Specialties list
Yes
Generic
No
SL addition date: 15/03/1988

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
47183
Drug name
Ovestin Ovula, Vaginalovula
Galenic form
VAGZ
ATC Code
G03CA04
Authorization status
Z
Dispensing category
B
First authorization
31/08/1987
Authorization expiration date
31/12/9999
IT Number
07.08.2.
Domain
Human medicine
Field of application
Vaginale Oestrogensubstitutionstherapie

Package details

Description (FR)
OVESTIN ovule 0.5 mg 15 pce
Description (DE)
OVESTIN Ovula 0.5 mg 15 Stk
Market launch
31/08/1987
Narcotic (BTM)
No
Buy us a coffee Explore the data